Delivery Order SPE2DB22D3501-SPE2DB26FTK98
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Femring 0.05 mg/day vaginal rings with a ceiling value of $1,159.81 under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value...
- The Defense Logistics Agency awarded a delivery order valued at $3,635.97 to AmerisourceBergen Drug Corp for the supply of Femring 0.05 mg/day vaginal rings. This is a firm fixed-price, non-set-aside contract awarded on September 18, 2025, with a completion date of September 19, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,333.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Femring 0.05 mg/day vaginal rings. This non-competitive delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 25, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle...
- This is a $1,193.47 fixed-price delivery order awarded to the Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of FEMRING 0.05 MG/DAY vaginal rings to the U.S. government. The award was made by the Medical Supply Chain, a defense agency under the Defense Logistics Agency (DLA) Troop Support. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
- The Defense Logistics Agency awarded a $1,359.28 firm fixed price delivery order to AmerisourceBergen Drug Corp for FEMRING 0.05 mg/day vaginal rings. This non-set-aside contract was awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, supplies the Defense Health...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of FEMRING 0.05 MG/DAY vaginal rings, with a potential value of $2,884.82 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide FEMRING 0.10 MG/DAY Vaginal Rings. The contract has a ceiling value of $1,768.00 and a performance period through March 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded to AmerisourceBergen Drug Corp, which serves as the primary vehicle for the...
- This is a delivery order under contract SPE2DB20D3104 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide FEMRING 0.05 MG/DAY vaginal rings. The $3,865.93 firm-fixed-price order has an ultimate completion date of August 18, 2021. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical through November 2026, which covers a...
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FEMRING 0.10 MG/DAY vaginal rings, with a ceiling value of $4,102.27 and an ultimate completion date of October 18, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the...
- This federal contract award, valued at $7,921.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FEMRING 0.05 MG/DAY vaginal rings, a medical product used for various healthcare applications. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTK98Delivery Order
The Defense Logistics Agency has awarded a delivery order valued at $1,544.87 to AmerisourceBergen Drug Corp for the supply of Femring 0.10 mg/day vaginal rings, with completion targeted for November 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support program enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare systems worldwide. AmerisourceBergen, one of the nation's largest pharmaceutical distributors, maintains an extensive portfolio of federal contracts with the DLA for diverse medical commodities across multiple therapeutic domains, demonstrating its critical role in supporting Defense Health Agency and other federal healthcare system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/6/25 |